Answers are grounded in this paper and cite their sources.
Patients with Liver Cirrhosis (LC) are at a high risk of developing bacterial infections. Spontaneous Bacterial Peritonitis (SBP) is the most common and sometimes fatal complication in LC patients. Therefore, novel and useful biomarkers for the early diagnosis of SBP are needed. Procalcitonin (PCT) is a biomarker used for the early diagnosis of bacterial infections in LC patients. However, the usefulness of PCT for diagnosing SBP in LC patients is yet unclear. This manuscript reviews data regarding PCT levels in the serum and ascites of patients with LC complicated by SBP.
No takes yet. Share an insight, caveat, or question.
Toru Shizuma (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: